Compare COO & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | CSL |
|---|---|---|
| Founded | 1980 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Specialty Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 17.1B |
| IPO Year | 1994 | 1994 |
| Metric | COO | CSL |
|---|---|---|
| Price | $62.88 | $355.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $90.18 | ★ $401.67 |
| AVG Volume (30 Days) | ★ 1.9M | 369.9K |
| Earning Date | 05-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.66 | ★ 3.10 |
| Revenue | $2,532,800,000.00 | ★ $5,003,600,000.00 |
| Revenue This Year | $6.66 | $2.59 |
| Revenue Next Year | $5.18 | $4.50 |
| P/E Ratio | ★ $92.64 | $111.60 |
| Revenue Growth | ★ 18.41 | 9.08 |
| 52 Week Low | $60.64 | $293.43 |
| 52 Week High | $89.83 | $435.92 |
| Indicator | COO | CSL |
|---|---|---|
| Relative Strength Index (RSI) | 27.13 | 52.17 |
| Support Level | $61.78 | $339.90 |
| Resistance Level | $70.01 | $368.95 |
| Average True Range (ATR) | 1.81 | 14.26 |
| MACD | -0.54 | 0.54 |
| Stochastic Oscillator | 17.10 | 26.67 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Carlisle Companies Inc is a holding company. The company manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. The company is organized into two segments including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing underlayments, integrated air and vapor barriers, spray polyurethane foam and coating systems, and others. The majority of the company's revenue comes from the Carlisle Construction Materials segment, and more than half of the total revenue is earned in the United States.